Virtu Financial LLC bought a new position in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN – Free Report) during the third quarter, HoldingsChannel.com reports. The firm bought 11,366 shares of the business services provider’s stock, valued at approximately $153,000.
Several other hedge funds also recently made changes to their positions in the business. Truvestments Capital LLC bought a new stake in shares of Cross Country Healthcare in the third quarter valued at approximately $39,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Cross Country Healthcare during the 3rd quarter valued at $49,000. nVerses Capital LLC acquired a new stake in shares of Cross Country Healthcare during the 2nd quarter worth $50,000. Point72 DIFC Ltd bought a new position in shares of Cross Country Healthcare in the third quarter worth $52,000. Finally, Gladius Capital Management LP raised its stake in Cross Country Healthcare by 83.4% in the third quarter. Gladius Capital Management LP now owns 3,985 shares of the business services provider’s stock valued at $54,000 after purchasing an additional 1,812 shares in the last quarter. 96.03% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on the company. Truist Financial upped their target price on Cross Country Healthcare from $15.00 to $18.61 and gave the stock a “hold” rating in a research note on Thursday, December 5th. William Blair downgraded Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 4th. Barrington Research reiterated a “market perform” rating on shares of Cross Country Healthcare in a research report on Tuesday, December 10th. StockNews.com started coverage on shares of Cross Country Healthcare in a report on Saturday, December 14th. They issued a “hold” rating for the company. Finally, Benchmark lowered shares of Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 4th. Five analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $18.54.
Cross Country Healthcare Price Performance
Cross Country Healthcare stock opened at $17.89 on Thursday. The business has a 50 day moving average of $12.81 and a 200-day moving average of $13.90. The company has a market capitalization of $588.89 million, a P/E ratio of -357.73, a P/E/G ratio of 3.39 and a beta of 0.61. Cross Country Healthcare, Inc. has a 1 year low of $9.58 and a 1 year high of $23.64.
About Cross Country Healthcare
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Further Reading
- Five stocks we like better than Cross Country Healthcare
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Investing In Automotive Stocks
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Want to see what other hedge funds are holding CCRN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cross Country Healthcare, Inc. (NASDAQ:CCRN – Free Report).
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.